<code id='512EB6B7EE'></code><style id='512EB6B7EE'></style>
      • <acronym id='512EB6B7EE'></acronym>
      <center id='512EB6B7EE'><center id='512EB6B7EE'><tfoot id='512EB6B7EE'></tfoot></center><abbr id='512EB6B7EE'><dir id='512EB6B7EE'><tfoot id='512EB6B7EE'></tfoot><noframes id='512EB6B7EE'>
      • <optgroup id='512EB6B7EE'><strike id='512EB6B7EE'><sup id='512EB6B7EE'></sup></strike><code id='512EB6B7EE'></code></optgroup>
        5. <b id='512EB6B7EE'><label id='512EB6B7EE'><select id='512EB6B7EE'><dt id='512EB6B7EE'><span id='512EB6B7EE'></span></dt></select></label></b><u id='512EB6B7EE'></u>
          <i id='512EB6B7EE'><strike id='512EB6B7EE'><tt id='512EB6B7EE'><pre id='512EB6B7EE'></pre></tt></strike></i>
           
   
   
   
 

  
           
   
           
    
           
     
          
       Home / entertainment / knowledge      
           
     
           
      
          knowledge 
           
      
           
      
           
       2025-10-01 13:44:55 
   
      
           
      
           
                        
          knowledge  
          
                                   
                 
                                      author：leisure time   
                                        
                                      
                                      Page View：4
                                  
                                    
          
                                   
          Editor’s note: A recording of the event is embedded below.
          After a few go-go years, the early-stage biotech market has cooled considerably. Two VCs will weigh in on what distinguishes great science from bad investments.
          advertisement
          Featured Speakers
          • Irena Melnikova, Ph.D., partner, Pfizer Ventures
          • Rakhshita Dhar, senior director, venture investments, Leaps by Bayer
          • Frank S. David, M.D., Ph.D., managing director, Pharmagellan (moderator)
          Get unlimited access to award-winning journalism and exclusive events.					
          Subscribe																						Log In															
                      
                              
          
                                 Previous article：

                                
                                          Readout Newsletter: Vertex, Pfizer, Kura, and other biotech news
                                
                            
          Next article：  
                                      
                                          As demand for Covid shots wanes, Moderna seeks its next success
                                                                    
          

      
           
    


       
       
       
    
     
           
    
           
    
           
   
      
     
           
      
           
       
          Related articles